Stryker Corporation (NYSE:SYK), a leading medical technologies firm with a market capitalization of $149.5 billion, announced the completion of a substantial debt offering, raising a total of $3 ...
Stryker Corp. plans to sell its U.S. spinal implant business to a New York-based family office Viscogliosi Brothers LLC.
Barclays analyst Matt Miksic raised the firm’s price target on Stryker (SYK) to $443 from $418 and keeps an Overweight rating on the shares.
Barclays analyst Matt Miksic maintained a Buy rating on Stryker (SYK – Research Report) today and set a price target of $443.00. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results